Saturday, February 04, 2012

Leukemia/Lymphoma

C05012
A Two-Arm Non Randomized, Multicenter, Phase II Study of Velcade in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin Followed by Rituximab Maintenance in Patients with Relapsed Follicular Lymphoma
CALGB 10603
A Phase III Randomized, Double Blind Study of Induction and Consolidation Chemotherapy + Midostaurin or Placebo in Newly Diagnosed Patients < 60 Years of Age with FLT3 Mutated Acute Myeloid Leukemia (AML)

We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.

For more information about the clinical trials listed please go to http://www.clinicaltrials.gov/.